Lgt Fund Management CO Ltd. Regeneron Pharmaceuticals, Inc. Transaction History
Lgt Fund Management CO Ltd.
- $1.1 Billion
- Q4 2024
A detailed history of Lgt Fund Management CO Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Lgt Fund Management CO Ltd. holds 560 shares of REGN stock, worth $393,556. This represents 0.04% of its overall portfolio holdings.
Number of Shares
560
Previous 452
23.89%
Holding current value
$393,556
Previous $475,000
16.21%
% of portfolio
0.04%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,490Shares Held
85.7MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.53 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.94 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.96 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.4 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.33 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $75.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...